The News
Medidata has expanded its partnership with The Menarini Group, leveraging its Study Build AI technology to enhance clinical workflows in oncology. This marks a new phase in their 14-year collaboration, focusing on accelerating Menarini's global oncology pipeline.
Why It Matters
The integration of AI into established clinical workflows signifies a strategic shift in how pharmaceutical companies can expedite drug development processes. This partnership showcases the growing trend of utilizing AI to enhance research efficiency, potentially leading to faster therapeutic advancements in oncology.
Key Evidence
The information is sourced from aktiencheck, a reliable reporting outlet, indicating a formal announcement regarding the partnership expansion.
Original Article
aktiencheck
DE source 路 Published 6d ago
https://www.aktiencheck.de/news/Artikel-Medidata_Expands_Partnership_with_The_Menarini_Group_Deploying_Medidata_s_Study_Build_AI_Technology_to_Accelerate_Global_Oncology_Pipeline-19542507